Key result
Drug-eluting stents significantly reduce restenosis and major adverse cardiac events compared with bare-metal stents, but show no difference in mortality or acute myocardial infarction.
Authors
Loading...
Supports DES preference to cut restenosis and MACE; leaves open mortality or MI differences versus BMS.
Key points are not available for this paper at this time.
Koolen et al. (2007) studied this question. Drug-eluting stents significantly reduce restenosis and major adverse cardiac events compared with bare-metal stents, but show no difference in mortality or acute myocardial infarction.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: